Elite Pharmaceuticals to Present SequestOx™ Data at the American Pain Society 35th Annual Scientific Meeting
09 mai 2016 07h30 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., May 09, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today it will present data for SequestOx™ (ELI-200) at the American...
Elite Pharmaceuticals Appoints Davis S. Caskey to Its Board of Directors
04 mai 2016 08h00 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., May 04, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today that its Board of Directors has appointed Davis S. Caskey to...
Elite Pharmaceuticals Announces Changes to their Board of Directors
12 avr. 2016 08h00 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., April 12, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today that its Board of Directors has appointed Eugene Pfeifer to...
Elite Announces U.S. FDA Priority Review Designation for SequestOx™ NDA
17 mars 2016 07h00 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., March 17, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today announced that the New Drug Application (NDA) for SequestOXTM...
Elite Pharmaceuticals, Inc. Reports Strong Growth for Third Quarter of Fiscal Year 2016
09 févr. 2016 16h31 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 09, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), announced results for the quarter ended December 31, 2015, the third quarter...
Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss 3rd Quarter 2016 Financial Results on February 10, 2016
05 févr. 2016 12h42 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 05, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
FDA Approves Waiver of NDA Filing Fee for Elite Pharmaceuticals
13 janv. 2016 16h51 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 13, 2016 (GLOBE NEWSWIRE) -- The United State Food and Drug Administration (“FDA”) granted Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) a waiver of the...
Nasrat Hakim Named Chairman of Board of Directors for Elite Pharmaceuticals
13 janv. 2016 09h24 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 13, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced that Jerry Treppel has resigned as the Company’s Chairman and as a...
Elite Pharmaceuticals, Inc. Reports Strong Growth for Second Quarter of Fiscal Year 2016
09 nov. 2015 16h37 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), announced results for the quarter ended September 30, 2015, the second...
Elite Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss 2nd Quarter 2016 Financial Results on November 10, 2015
05 nov. 2015 17h12 HE
|
Elite Pharmaceuticals, Inc.
Northvale, NJ, Nov. 05, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB: ELTP), a specialty pharmaceutical company developing a pipeline of...